# Sencure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sencure-b-v

- Industry: Medical Devices & Equipment
- Headquarters: Roden, Netherlands
- Website: www.sencure.com
- Total disclosed funding: $4.1M
- Latest round: Series B (Jan 1, 2025)
- Investors on record: 4

## About

Sencure B.V. specializes in advanced integrated circuit technology for medical devices and health-tracking wearables, focusing on efficient power consumption and high signal quality.Founded in 2021 and headquartered in the Netherlands, Sencure B.V. develops integrated circuit solutions for health-tracking applications. The company has engaged in ventures to enhance its operational capabilities, with Dick van Waes serving as CEO. In April 2021, Sencure raised EUR 1 million in funding led by Cottonwood Technology Fund and Lumana Invest for its growth initiatives. The company has made one investment deal to date.Sencure specializes in integrated circuit technology specifically designed for medical devices and health-tracking wearables, optimizing power consumption while enhancing signal quality. The core product, the SNCE800, combines an Analog Front-end, Analog-to-Digital converter, and a Digital Signal Processor, facilitating high-quality electrophysiological measurements from brain (EEG), heart (ECG), and muscle (EMG) signals. This technology supports advanced wearable medical applications such as pregnancy monitoring and asthma management through innovative patches and textile-integrated sensors. Sencure seeks partnerships in Europe and beyond, particularly in the health tracking and medical device sectors.Sencure generates revenue primarily through partnerships and collaborations with industry players, including universities and medical institutions. The sales of the SNCE800 integrated circuit and associated evaluation kits drive their business model, typically through B2B agreements with medical device manufacturers. Specific pricing details for the SNCE800 and related services are not disclosed. The firm aims to foster long-term partnerships to provide tailored technology solutions for medical wearables, ensuring steady revenue from ongoing collaborations and potential licensing agreements.In April 2021, Sencure B.V. raised EUR 1 million in funding to support its future growth initiatives. The company plans to file patent applications to protect its unique intellectual property and develop its product offerings further. Sencure is targeting the global rollout of its products, particularly in markets that require robust health monitoring solutions, and aims to expand its presence in new geographic regions.

## Funding rounds

- Series B, Jan 1, 2025, $4.1M — Cottonwood Technology Fund, NOM, 819 Capital Partners, Bluegrass Ventures

## Investors

- Cottonwood Technology Fund (https://capitalatlas.ai/funds/cottonwood-technology-fund) — Series B
- NOM (https://capitalatlas.ai/funds/nom) — Series B
- 819 Capital Partners (https://capitalatlas.ai/funds/819-capital-partners) — Series B
- Bluegrass Ventures (https://capitalatlas.ai/funds/bluegrass-ventures) — Series B